科研动态PubMed 摘要

心力衰竭患者中利尿剂抵抗的全球患病率变化:一项系统评价和累积荟萃分析。

PubMed 学科轮询 · 2026-10-17

完整摘要 · 中文译文

背景:利尿剂抵抗(DR)是心力衰竭管理中的一项重大挑战,可导致持续性淤血、住院时间延长和不良结局。然而,DR定义和研究设计的不一致导致患病率估计不确定,并限制了指南的制定。 目的:使用具有有效心力衰竭分母且可提取二分类DR事件的研究,确定心力衰竭中DR的合并患病率,并评估患病率估计随时间变化的稳定性和异质性。 数据来源:检索PubMed、EMBASE、Scopus、Cochrane系统评价数据库、科学引文索引、WHO国际临床试验注册平台(ICTRP)和效果评价摘要数据库,检索时间范围为2000年至2026年最终更新检索,并辅以参考文献筛选。 研究选择:与成人心力衰竭DR相关的观察性研究和随机研究被纳入系统评价考虑范围。对于定量患病率分析,研究需包含未选择或连续纳入的心力衰竭分母,以及基于队列进入后出现的预设或研究定义标准所得的可提取二分类DR事件计数。仅纳入已确诊DR患者、仅报告连续性利尿剂反应指标或缺乏有效二分类DR分子的研究被排除于患病率合并之外,但仍可能与定性系统评价相关。两名评价者独立提取数据。患病率为p 采用逆方差随机效应模型在logit尺度上进行合并,研究间方差采用限制性最大似然估计,并采用Hartung-Knapp推断。进行了异质性分析、预测区间、累积荟萃分析、影响分析与敏感性分析、广义线性混合模型稳健性分析以及探索性漏斗图不对称性检验。 结果:共纳入12项符合患病率纳入标准的研究,涉及24,904例患者进入定量患病率分析,其中4,861例符合研究定义的DR标准。合并患病率为23.0%(95% CI,13.6%-36.2%),存在显著异质性(I²=98.5%;τ²=0.851;Q = 757.17,df=11;p < 0.001)。95%预测区间为3.4%-71.6%。广义线性混合模型得出的合并患病率相似,为22.5%(95% CI,14.5%-33.2%)。累积分析显示,随着新的符合条件研究的累积,估计值发生变化,在纳入最近的研究后达到23.0%。探索性回归分析未显示具有统计学意义的漏斗图不对称性(p = 0.072)。 结论:在符合患病率纳入标准的队列中,约四分之一的心力衰竭患者符合研究定义的DR标准。然而,极宽的预测区间和极端异质性表明,DR的发生频率在很大程度上取决于人群、环境、评估时机和操作性定义。需要标准化的诊断标准和前瞻性组建的患病率队列,以提高可比性并指导临床实践。

完整摘要 · 英文原文

BACKGROUND: Diuretic resistance (DR) is a major challenge in the management of heart failure, contributing to persistent congestion, prolonged hospitalization, and adverse outcomes. However, inconsistent DR definitions and study designs have resulted in uncertain prevalence estimates and limited guideline development. OBJECTIVE: To determine the pooled prevalence of DR in heart failure using studies with valid heart-failure denominators and extractable binary DR events, and to evaluate the stability and heterogeneity of prevalence estimates over time. DATA SOURCES: PubMed, EMBASE, Scopus, the Cochrane Database of Systematic Reviews, Science Citation Index, WHO International Clinical Trials Registry Platform (ICTRP), and the Database of Abstracts of Reviews of Effects were searched from 2000 through the final updated search in 2026, supplemented by reference screening. STUDY SELECTION: Observational studies and randomized studies relevant to DR in adults with heart failure were considered for the systematic review. For the quantitative prevalence analysis, studies were required to include an unselected or consecutively assembled heart-failure denominator and an extractable binary DR event count based on a prespecified or study-defined criterion arising after cohort entry. Studies enrolling only patients with established DR, reporting only continuous diuretic-response measures, or lacking a valid binary DR numerator were excluded from prevalence pooling but could remain relevant to the qualitative systematic review. Two reviewers independently extracted data. Prevalence was pooled on the logit scale using an inverse-variance random-effects model with restricted maximum likelihood estimation of between-study variance and Hartung-Knapp inference. Heterogeneity, prediction intervals, cumulative meta-analysis, influence and sensitivity analyses, a generalized linear mixed-model robustness analysis, and exploratory funnel-plot asymmetry testing were undertaken. RESULTS: Twelve prevalence-eligible studies involving 24,904 patients were included in the quantitative prevalence analysis, of whom 4,861 met study-defined criteria for DR. The pooled prevalence was 23.0% (95% CI, 13.6%-36.2%), with substantial heterogeneity (I²=98.5%; τ²=0.851; Q = 757.17, df=11; p < 0.001). The 95% prediction interval was 3.4%-71.6%. A generalized linear mixed model yielded a similar pooled prevalence of 22.5% (95% CI, 14.5%-33.2%). Cumulative analysis showed that the estimate changed as new eligible studies accrued, reaching 23.0% after inclusion of the most recent studies. Exploratory regression analysis did not demonstrate statistically significant funnel-plot asymmetry (p = 0.072). CONCLUSION: Approximately one in four patients with heart failure meets a study-defined criterion for DR in prevalence-eligible cohorts. However, the very wide prediction interval and extreme heterogeneity show that DR frequency is strongly dependent on population, setting, timing of assessment, and operational definition. Standardized diagnostic criteria and prospectively assembled prevalence cohorts are required to improve comparability and guide clinical practice.

English
Changing global prevalence of diuretic resistance amongst patients with heart failure: a systematic review and cumulative meta-analyses.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界